[1] Bundhun P K, Sookharee Y, Bholee A, et al. Application of the SYNTAX score in interventional cardiology: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2017, 96(28): e7410
[2] Dickson B C, Gotlieb A I. Towards understanding acute destabilization of vulnerable atherosclerotic plaques[J]. Cardiovasc Pathol, 2003, 12(5): 237
[3] Palmerini T, Calabrò P, Piscione F, et al. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study[J]. JACC Cardiovasc Interv, 2014, 7(10):1117
[4] Soehnlein O. Decision shaping neutrophil-platelet interplay in inflammation: from physiology to intervention[J]. Eur J Clin Invest, 2018, 48(2). doi: 10.1111/eci.12871
[5] Sreeramkumar V, Adrover J M, Ballesteros I, et al. Neutrophils scan for activated platelets to initiate inflammation[J]. Science, 2014, 346(6214): 1234
[6] Huebener P, Pradere J P, Hernandez C, et al. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis[J]. J Clin Invest, 2019, 130: 1802
[7] Cimmino G, Loffredo F S, Morello A, et al. Immune-inflammatory activation in acute coronary syndromes: a look into the heart of unstable coronary plaque[J]. Curr Cardiol Rev, 2017, 13(2): 110
[8] Flego D, Liuzzo G, Weyand C M, et al. Adaptive immunity dysregulation in acute coronary syndromes: from cellular and molecular basis to clinical implications[J]. J Am Coll Cardiol, 2016, 68(19): 2107
[9] Ruggio A, Pedicino D, Flego D, et al. Correlation between CD4+CD28null T lymphocytes, regulatory T cells and plaque rupture: an optical coherence tomography study in acute coronary syndromes[J]. Int J Cardiol, 2019, 276: 289
[10] Akkaya E, Gul M, Ugur M. Platelet to lymphocyte ratio: a simple and valuable prognostic marker for acute coronary syndrome[J]. Int J Cardiol, 2014, 177(2):597
[11] Kurtul A, Murat S N, Yarlioglues M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes[J]. Am J Cardiol, 2014, 114(7):972
[12] Oylumlu M, Y?覦ld?覦z A, Oylumlu M, et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome[J]. Anatol J Cardiol, 2015, 15(4):277
[13] Ozcan Cetin E H, Cetin M S, Aras D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial Infarction[J]. Angiology, 2016, 67(4):336
[14] Zhang W W, Liu K J, Hu G L, et al. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients[J]. Tumour Biol, 2015, 36(11): 8831
[15] Diem S, Schmid S, Krapf M, et al. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab[J]. Lung Cancer, 2017, 111: 176
[16] Ma X M, Sun X, Yang G W, et al. The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis[J]. Climacteric, 2017, 20(5): 448
[17] Sianos G, Morel M A, Kappetein A P, et al.The SYNTAX score:an angiographic tool grading the complexity of coronary artery disease[J]. EuroIntervention,2005,1: 219
[18] Caixeta A, Généreux P, Palmerini T, et al. Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategY [ACUITY] trial) [J]. Am J Cardiol, 2014, 113(2):203
[19] Li H, Zhou Y, Ma Y, et al. The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome: a systematic review and meta-analysis[J]. Kardiol Pol, 2017, 75(7): 666
[1]张程征,袁如玉.女性早发急性冠脉综合征血压变异性的研究[J].天津医科大学学报,2014,20(02):127.
ZHANG Cheng-zheng,YUAN Ru-yu.Blood pressure variability in female patients with premature acute coronary syndrome[J].Journal of Tianjin Medical University,2014,20(06):127.
[2]孙丽丽,李广平,刘相丽,等. ACS患者血清脂蛋白相关磷脂酶A2水平与GRACE评分的相关性 [J].天津医科大学学报,2015,21(04):324.
SUN Li-li,LI Guang-ping,LIU Xiang-li,et al.Correlation between lipoprotein-associated phospholipase A2 levels and global registey of acute coronary event score in patients with acute coronary syndromes[J].Journal of Tianjin Medical University,2015,21(06):324.
[3]刘燕霞,刘相丽.情绪障碍对ACS患者NLR水平和GRACE评分危险分层的影响[J].天津医科大学学报,2019,25(03):267.
LIU Yan-xia,LIU Xiang-li.Effects of mood disorders on NLR and risk stratification of GRACE scores in ACS patients[J].Journal of Tianjin Medical University,2019,25(06):267.
[4]王 珂,石继红,魏振衡.替格瑞洛、氯吡格雷对急性冠脉综合征患者PCI术后血小板聚集率、血流动力学及免疫功能的影响[J].天津医科大学学报,2020,26(01):35.
WANG Ke,SHI Ji-hong,WEI Zhen-heng.The effects of Ticagrelor and Clopidogrel on platelet aggregation rate, hemodynamics and immunologic function in patients with acute coronary syndrome after PCI[J].Journal of Tianjin Medical University,2020,26(06):35.
[5]郝增光,韩兆帅,葛慧敏.血小板与淋巴细胞比值评估合并多支血管病变的急性心肌梗死患者预后的价值[J].天津医科大学学报,2021,27(02):150.
HAO Zeng-guang,HAN Zhao-shuai,GE Hui-min.The value of platelet to lymphocyte ratio in evaluating the prognosis of patients with acute myocardial infarction combined with multivessel disease[J].Journal of Tianjin Medical University,2021,27(06):150.